139 related articles for article (PubMed ID: 18951925)
21. The involvement of cannabinoids and mTOR in the reconsolidation of an emotional memory in the hippocampal-amygdala-insular circuit.
Zubedat S; Akirav I
Eur Neuropsychopharmacol; 2017 Apr; 27(4):336-349. PubMed ID: 28131675
[TBL] [Abstract][Full Text] [Related]
22. Behavioral sensitization to heroin by cannabinoid pretreatment in the rat.
Pontieri FE; Monnazzi P; Scontrini A; Buttarelli FR; Patacchioli FR
Eur J Pharmacol; 2001 Jun; 421(3):R1-3. PubMed ID: 11516439
[TBL] [Abstract][Full Text] [Related]
23. Selective lack of tolerance to delayed gastric emptying after daily administration of WIN 55,212-2 in the rat.
Abalo R; Cabezos PA; López-Miranda V; Vera G; González C; Castillo M; Fernández-Pujol R; Martín MI
Neurogastroenterol Motil; 2009 Sep; 21(9):1002-e80. PubMed ID: 19413685
[TBL] [Abstract][Full Text] [Related]
24. Long-lasting increase of alcohol relapse by the cannabinoid receptor agonist WIN 55,212-2 during alcohol deprivation.
López-Moreno JA; González-Cuevas G; Rodríguez de Fonseca F; Navarro M
J Neurosci; 2004 Sep; 24(38):8245-52. PubMed ID: 15385608
[TBL] [Abstract][Full Text] [Related]
25. Cannabinoids attenuate capsaicin-evoked hyperalgesia through spinal and peripheral mechanisms.
Johanek LM; Heitmiller DR; Turner M; Nader N; Hodges J; Simone DA
Pain; 2001 Sep; 93(3):303-315. PubMed ID: 11514089
[TBL] [Abstract][Full Text] [Related]
26. Cannabinoid self-administration in rats: sex differences and the influence of ovarian function.
Fattore L; Spano MS; Altea S; Angius F; Fadda P; Fratta W
Br J Pharmacol; 2007 Nov; 152(5):795-804. PubMed ID: 17891164
[TBL] [Abstract][Full Text] [Related]
27. Cannabinoid system of the lateral septum in the modulation of anxiety-like behaviors in rats.
Hajizadeh Moghaddam A; Bigdellu R; Fatemi Tabatabaei SR; Roohbakhsh A
Arch Iran Med; 2013 Dec; 16(12):711-6. PubMed ID: 24329144
[TBL] [Abstract][Full Text] [Related]
28. Acute and chronic cannabinoid treatment differentially affects recognition memory and social behavior in pubertal and adult rats.
Schneider M; Schömig E; Leweke FM
Addict Biol; 2008 Sep; 13(3-4):345-57. PubMed ID: 18782382
[TBL] [Abstract][Full Text] [Related]
29. The cannabinoid WIN 55,212-2-mediated protection of dentate gyrus granule cells is driven by CB1 receptors and modulated by TRPA1 and Cav 2.2 channels.
Koch M; Kreutz S; Böttger C; Grabiec U; Ghadban C; Korf HW; Dehghani F
Hippocampus; 2011 May; 21(5):554-64. PubMed ID: 20135626
[TBL] [Abstract][Full Text] [Related]
30. Effects of prenatal exposure to the CB-1 receptor agonist WIN 55212-2 or CO on the GABAergic neuronal systems of rat cerebellar cortex.
Benagiano V; Lorusso L; Flace P; Girolamo F; Rizzi A; Sabatini R; Auteri P; Bosco L; Cagiano R; Ambrosi G
Neuroscience; 2007 Nov; 149(3):592-601. PubMed ID: 17916407
[TBL] [Abstract][Full Text] [Related]
31. Cannabinoids and traumatic stress modulation of contextual fear extinction and GR expression in the amygdala-hippocampal-prefrontal circuit.
Ganon-Elazar E; Akirav I
Psychoneuroendocrinology; 2013 Sep; 38(9):1675-87. PubMed ID: 23433741
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of spontaneous neurotransmission in the nucleus of solitary tract of the rat by the cannabinoid agonist WIN 55212-2 is not via CB1 or CB2 receptors.
Accorsi-Mendonça D; Almado CE; Dagostin AL; Machado BH; Leão RM
Brain Res; 2008 Mar; 1200():1-9. PubMed ID: 18308297
[TBL] [Abstract][Full Text] [Related]
33. Evidence that spatial memory deficits following bilateral vestibular deafferentation in rats are probably permanent.
Baek JH; Zheng Y; Darlington CL; Smith PF
Neurobiol Learn Mem; 2010 Oct; 94(3):402-13. PubMed ID: 20736074
[TBL] [Abstract][Full Text] [Related]
34. Large receptor reserve for cannabinoid actions in the central nervous system.
Gifford AN; Bruneus M; Gatley SJ; Lan R; Makriyannis A; Volkow ND
J Pharmacol Exp Ther; 1999 Feb; 288(2):478-83. PubMed ID: 9918548
[TBL] [Abstract][Full Text] [Related]
35. Chronic pubertal, but not adult chronic cannabinoid treatment impairs sensorimotor gating, recognition memory, and the performance in a progressive ratio task in adult rats.
Schneider M; Koch M
Neuropsychopharmacology; 2003 Oct; 28(10):1760-9. PubMed ID: 12888772
[TBL] [Abstract][Full Text] [Related]
36. The CB receptor agonist WIN 55,212-2 fails to elicit disruption of prepulse inhibition of the startle in Sprague-Dawley rats.
Bortolato M; Aru GN; Frau R; Orrù M; Luckey GC; Boi G; Gessa GL
Psychopharmacology (Berl); 2005 Jan; 177(3):264-71. PubMed ID: 15290008
[TBL] [Abstract][Full Text] [Related]
37. Activation of CB1 cannabinoid receptors in rat hippocampal slices inhibits potassium-evoked cholecystokinin release, a possible mechanism contributing to the spatial memory defects produced by cannabinoids.
Beinfeld MC; Connolly K
Neurosci Lett; 2001 Mar; 301(1):69-71. PubMed ID: 11239718
[TBL] [Abstract][Full Text] [Related]
38. The cannabinoid receptor agonist WIN 55,212-2 mesylate blocks the development of hyperalgesia produced by capsaicin in rats.
Li J; Daughters RS; Bullis C; Bengiamin R; Stucky MW; Brennan J; Simone DA
Pain; 1999 May; 81(1-2):25-33. PubMed ID: 10353490
[TBL] [Abstract][Full Text] [Related]
39. Methamphetamine neurotoxicity increases brain expression and alters behavioral functions of CB₁ cannabinoid receptors.
Bortolato M; Frau R; Bini V; Luesu W; Loriga R; Collu M; Gessa GL; Ennas MG; Castelli MP
J Psychiatr Res; 2010 Oct; 44(14):944-55. PubMed ID: 20378129
[TBL] [Abstract][Full Text] [Related]
40. Topical cannabinoid agonist, WIN55,212-2, reduces cornea-evoked trigeminal brainstem activity in the rat.
Bereiter DA; Bereiter DF; Hirata H
Pain; 2002 Oct; 99(3):547-556. PubMed ID: 12406531
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
